Product Information

ESCITALOPRAM 5 MG TABLET is a generic product labeled by Cipla USA Inc., priced at $0.0441 per EA under NDC 69097084715. Its NADAC has been published 103 times since Dec 4, 2024.

FDA first approved this application on Sep 11, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ESCITALOPRAM 5 MG TABLET

Escitalopram
$0.0441per EA

Strength

5 mg/1

Manufacturer

Cipla USA Inc.

NDC

69097084715

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

ESCITALOPRAM OXALATE

Approval Type

Generic (ANDA)

FDA Application

ANDA078604

FDA Approved

9/11/2012

TE Code

AB

On Market Since

6/16/2016

Pharmacological Classes

Serotonin Reuptake Inhibitor
Serotonin Uptake Inhibitors

Price Statistics

The NADAC for ESCITALOPRAM 5 MG TABLET has been published 103 times since Dec 4, 2024, and over the history we have for it it has risen 34.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0441 per EA
All-time high$0.0474 (Jul 16, 2025)
All-time low$0.0328 (Dec 4, 2024)
52-week high$0.0441
52-week low$0.0412
Median price$0.0421
Average price$0.0426
Largest weekly change+13.8% (Dec 18, 2024)
Weeks tracked103
Tracking sinceDec 4, 2024

Price History

1W

+2.8%

1M

+6.0%

3M

+5.1%

6M

+5.2%

1Y

+6.9%

3Y

N/A

5Y

N/A

All

+34.6%

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 5% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of ESCITALOPRAM 5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for ESCITALOPRAM 5 MG TABLET, manufactured by Cipla USA Inc., is $0.0441 per EA (NDC 69097084715), effective Nov 18, 2026.

How has the price of ESCITALOPRAM 5 MG TABLET changed over time?

Over the history we have for it, the NADAC for ESCITALOPRAM 5 MG TABLET has risen 34.6%. It has been tracked across 103 weekly CMS publications since Dec 4, 2024.

What are the highest and lowest recorded NADAC prices for ESCITALOPRAM 5 MG TABLET?

Since Dec 4, 2024, the NADAC for ESCITALOPRAM 5 MG TABLET has ranged from a low of $0.0328 (Dec 4, 2024) to a high of $0.0474 (Jul 16, 2025), with a median of $0.0421 per EA.

Are there cheaper alternatives to ESCITALOPRAM 5 MG TABLET?

Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ESCITALOPRAM 5 MG TABLET, is $0.0419 per EA — about 5% below ESCITALOPRAM 5 MG TABLET.

Who manufactures ESCITALOPRAM 5 MG TABLET?

ESCITALOPRAM 5 MG TABLET (NDC 69097084715) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.